Barbara Frederick - Concepedia

Author

Barbara Frederick

Also Known As

B Frederick, B Fréderick, B Frédérick, B. Frederick, B. Fréderick, B. Frédérick, B.A. Frederick, Barbara A. Frederick, Barbara Frederick, Frederick B.

109

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Colorado Denver University of Colorado Anschutz Medical Campus University of Colorado Boulder University of Colorado Cancer Center University of Colorado Health

About

Barbara Frederick is an author at University of Colorado Denver specializing in medicine, oncology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	555
2	Natural Sciences	2	2	97
3	Biochemistry	2	2	48
4	Biology	2	2	97
5	Health Sciences	1	1	21

Barbara Frederick

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules Anand Ramteke, Harold J. Ting, Chapla Agarwal, Molecular Carcinogenesis	2013	383
Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non–small cell lung carcinoma Barbara Frederick, Barbara A. Helfrich, Christopher D. Coldren, Molecular Cancer Therapeutics	2007	273
Cortactin Overexpression Regulates Actin-Related Protein 2/3 Complex Activity, Motility, and Invasion in Carcinomas with Chromosome 11q13 Amplification B. L. Rothschild, Ann Hye-Ryong Shim, Amanda G. Ammer, Cancer Research Radiation OncologyHnscc CasesCell RegulationHnscc CellsMedicine	2006	162
Fibroblast Growth Factor Receptors Are Components of Autocrine Signaling Networks in Head and Neck Squamous Cell Carcinoma Cells Marianne E. Marshall, Trista K. Hinz, Scott A. Kono, Clinical Cancer Research	2011	106
Saracatinib Impairs Head and Neck Squamous Cell Carcinoma Invasion by Disrupting Invadopodia Function Amanda G. Ammer, Laura C. Kelley, Karen E. Hayes, Journal of Cancer Science & Therapy Saracatinib Impairs HeadSrc KinaseMalignant DiseaseMedicineSaracatinib Treatment	2009	79
Resveratrol Selectively Induces DNA Damage, Independent of <i>Smad4</i> Expression, in Its Efficacy against Human Head and Neck Squamous Cell Carcinoma Alpna Tyagi, Mallikarjuna Gu, Takenori Takahata, Clinical Cancer Research	2011	76
Hedgehog Signaling Drives Radioresistance and Stroma-Driven Tumor Repopulation in Head and Neck Squamous Cancers Gregory N. Gan, Justin R. Eagles, Stephen B. Keysar, Cancer Research Gli1 ExpressionPathologyCancer BiologyTreatment ResistanceTumor Biology	2014	68
Melanin Synthesis Is Associated with Changes in Hyphopodial Turgor, Permeability, and Wall Rigidity inGaeumannomyces graminisvar.graminis Nicholas P. Money, Thecan Caesar‐TonThat, Barbara Frederick, Fungal Genetics and Biology BiologyDevelopmental BiologyBotanyMedicineNatural Sciences	1998	59
Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima®) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenografts Daniel L. Gustafson, Barbara Frederick, Andrea L. Merz, Cancer Chemotherapy and Pharmacology Dose SchedulingOncologyRadiation TherapyMedicineHead And Neck Cancer	2007	46
The Antioxidant, MnTE-2-PyP, Prevents Side-Effects Incurred by Prostate Cancer Irradiation Rebecca E. Oberley‐Deegan, Joshua J. Steffan, Kyle O. Rove, PLoS ONE UrologyOncologyRadiation TherapyErectile DysfunctionMedicine	2012	45

Page 1